NCT06805591

Brief Summary

The goal of this observational study is to learn about the effects of a low-pressure environment on the brain in patients with intracranial hypotension and to potentially improve diagnostics and treatment of this condition. The primary objective will be: To investigate the change in clinical biomarkers measured before and after successful treatment. The secondary objectives will be: To investigate if clinical biomarkers can predict the outcome of treatment. Participants undergoing standard treatment for intracranial hypotension will undergo additional examinations and surveys and will be followed up for a year for the study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
42mo left

Started Dec 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Dec 2024Sep 2029

Study Start

First participant enrolled

December 10, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 3, 2025

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2029

Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

4.8 years

First QC Date

January 28, 2025

Last Update Submit

February 3, 2025

Conditions

Keywords

Spontaneous Intracranial HypotensionSIHPost-Lumbar Puncture HeadachePLPHDanish Headache CenterPost-Dural Puncture HeadachePDPH

Outcome Measures

Primary Outcomes (1)

  • To investigate the change in clinical biomarkers measured before and after successful treatment.

    From enrollment to 1 year post-treatment.

Study Arms (2)

Patients with suspected Intracranial Hypotension

Patients will be included in the cohort if suspected of intracranial hypotension. The group will therefore be subgrouped into patients with spontaneous intracranial Hypotension, post-lumbar puncture headache, and patients suspected but not demonstrated with intracranial hypotension.

Control Group

Group consisting of healthy control participants.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at the Danish Headache Center with suspected intracranial hypotension

You may qualify if:

  • Age 18-80.
  • Patients with a suspected intracranial hypotension diagnosis.
  • Participants must read and understand the Danish language or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study.
  • Age 18-80.
  • Healthy people who do not suffer from any form of primary headache except infrequent tension-type headache.
  • Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study.

You may not qualify if:

  • Pregnant or breastfeeding females
  • Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases.
  • The patient has a disease, takes medication, or abuses alcohol or drugs that could, in the investigator´s opinion interfere with the assessments of safety, tolerability, or efficacy, or interfere with the conduct or interpretation of the study.
  • The patient is, in the investigator´s opinion, unlikely to comply with the protocol or is unsuitable for any reason.
  • Pregnant or breastfeeding females
  • Participants in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases.
  • The participant has a disease, takes medication, or abuses alcohol or drugs that could, in the investigator´s opinion interfere with the interpretation of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danish Headache Center

Glostrup Municipality, Copenhagen, 2600, Denmark

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood and cerebrospinal fluid

MeSH Terms

Conditions

Intracranial HypotensionPost-Dural Puncture Headache

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesHeadache Disorders, SecondaryHeadache Disorders

Study Officials

  • Henrik W Schytz, MD, Ph.D. DMSc

    Danish Headache Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Consultant Neurologist

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 3, 2025

Study Start

December 10, 2024

Primary Completion (Estimated)

September 30, 2029

Study Completion (Estimated)

September 30, 2029

Last Updated

February 6, 2025

Record last verified: 2025-02

Locations